APA
Kalogirou C., Spahn M., Krebs M., Joniau S., Lerut E., Burger M., Scholz C., Kneitz S., Riedmiller H. & Kneitz B. (20140603). MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. : International journal of molecular sciences.
Chicago
Kalogirou Charis, Spahn Martin, Krebs Markus, Joniau Steven, Lerut Evelyne, Burger Maximilian, Scholz Claus-Jürgen, Kneitz Susanne, Riedmiller Hubertus and Kneitz Burkhard. 20140603. MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. : International journal of molecular sciences.
Harvard
Kalogirou C., Spahn M., Krebs M., Joniau S., Lerut E., Burger M., Scholz C., Kneitz S., Riedmiller H. and Kneitz B. (20140603). MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. : International journal of molecular sciences.
MLA
Kalogirou Charis, Spahn Martin, Krebs Markus, Joniau Steven, Lerut Evelyne, Burger Maximilian, Scholz Claus-Jürgen, Kneitz Susanne, Riedmiller Hubertus and Kneitz Burkhard. MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. : International journal of molecular sciences. 20140603.